Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model.
Saved in:
| Title: | Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model. |
|---|---|
| Authors: | Ionescu A; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 69978, Israel., Gradus T; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel., Altman T; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel., Maimon R; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel., Saraf Avraham N; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel., Geva M; Teva Pharmaceuticals Ltd, Petah Tikva, Israel.; Prilenia Therapeutics, Herzliya, Israel., Hayden M; Teva Pharmaceuticals Ltd, Petah Tikva, Israel.; Prilenia Therapeutics, Herzliya, Israel., Perlson E; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel. eranpe@tauex.tau.ac.il.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 69978, Israel. eranpe@tauex.tau.ac.il. |
| Source: | Cell death & disease [Cell Death Dis] 2019 Mar 01; Vol. 10 (3), pp. 210. Date of Electronic Publication: 2019 Mar 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30824685 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1<superscript>G93A</superscript> Model. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ionescu+A%22">Ionescu A</searchLink>; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 69978, Israel.<br /><searchLink fieldCode="AU" term="%22Gradus+T%22">Gradus T</searchLink>; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel.<br /><searchLink fieldCode="AU" term="%22Altman+T%22">Altman T</searchLink>; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel.<br /><searchLink fieldCode="AU" term="%22Maimon+R%22">Maimon R</searchLink>; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel.<br /><searchLink fieldCode="AU" term="%22Saraf+Avraham+N%22">Saraf Avraham N</searchLink>; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel.<br /><searchLink fieldCode="AU" term="%22Geva+M%22">Geva M</searchLink>; Teva Pharmaceuticals Ltd, Petah Tikva, Israel.; Prilenia Therapeutics, Herzliya, Israel.<br /><searchLink fieldCode="AU" term="%22Hayden+M%22">Hayden M</searchLink>; Teva Pharmaceuticals Ltd, Petah Tikva, Israel.; Prilenia Therapeutics, Herzliya, Israel.<br /><searchLink fieldCode="AU" term="%22Perlson+E%22">Perlson E</searchLink>; Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel. eranpe@tauex.tau.ac.il.; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 69978, Israel. eranpe@tauex.tau.ac.il. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2019 Mar 01; Vol. 10 (3), pp. 210. <i>Date of Electronic Publication: </i>2019 Mar 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30824685 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41419-019-1451-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 210 Titles: – TitleFull: Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ionescu A – PersonEntity: Name: NameFull: Gradus T – PersonEntity: Name: NameFull: Altman T – PersonEntity: Name: NameFull: Maimon R – PersonEntity: Name: NameFull: Saraf Avraham N – PersonEntity: Name: NameFull: Geva M – PersonEntity: Name: NameFull: Hayden M – PersonEntity: Name: NameFull: Perlson E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2019 Mar 01 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2041-4889 Numbering: – Type: volume Value: 10 – Type: issue Value: 3 Titles: – TitleFull: Cell death & disease Type: main |
| ResultId | 1 |
